1 |
S. Frame, P. Cohen, and R. M. Biondi, "A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation", Mol. Cell, Vol. 7, pp. 1321-1327, 2001.
DOI
ScienceOn
|
2 |
N. Embi, D. B. Rylatt, and P. Cohen, "Glycogen synthase kinase-3 from rabbit skeletal muscle", European journal of biochemistry, Vol. 107, pp. 519-527, 1980.
|
3 |
S. E. Nikoulina, T. P. Ciaraldi, S. Mudaliar, P. Mohideen, L. Carter, and R. R. Henry, "Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes", Diabetes, Vol. 49, pp. 263-271, 2000.
DOI
ScienceOn
|
4 |
E. Planel, X. Sun, and A. Takashima, "Role of GSK- in Alzheimer's disease pathology", Drug Develop. Res., Vol. 56, pp. 491-510, 2002.
DOI
ScienceOn
|
5 |
C. J. Phiel and P. S. Klein, "Molecular targets of lithium action", Annu. Rev. Pharmacol., Vol. 41, pp. 789-813, 2001.
DOI
ScienceOn
|
6 |
M. K. Rowe, C. Wiest, and D.-M. Chuang, "GSK-3 is a viable potential target for therapeutic intervention in bipolar disorder", Neurosci. Biobehav. R., Vol. 31, pp. 920-931, 2007.
DOI
ScienceOn
|
7 |
R. S. Jope and M.-S. Roh, "Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions", Curr. Drug Targets, Vol. 7, pp. 1421-1434, 2006.
DOI
|
8 |
M. P. Mazanetz and P. M. Fischer, "Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases", Nat. Rev. Drug Discov., Vol. 6, pp. 464-479, 2007.
DOI
ScienceOn
|
9 |
P. K. Balasubramanian and S. J. Cho, "HQSAR analysis on novel series of 1-(4-phenylpiperazin-1-yl-2-(1H-Pyrazol-1-yl) ethanone derivatives targeting CCR1", J. Chosun Natural Sci., Vol. 6, pp. 163-169, 2013.
DOI
ScienceOn
|
10 |
S. J. Cho, "The importance of halogen bonding: a tutorial", J. Chosun Natural Sci., Vol. 5, pp. 195-197, 2012.
DOI
ScienceOn
|
11 |
C. G. Gadhe, G. Kothandan, and Seung Joo Cho, "Large variation in electrostatic contours upon addition of steric parameters and the effect of charge calculation schemes in CoMFA on mutagenicity of MX analogues", Mol. Simulat., Vol. 38, pp. 861-871, 2012.
DOI
|
12 |
SYBYLx2.1, Tripos International, 1699 South Hanley Road, St. Louis, Missouri, 63144, USA.
|
13 |
R. D. Cramer, D. E. Patterson, and J. D. Bunce, "Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins", J. Am. Chem. Soc., Vol. 110, pp. 5959-5967, 1988.
DOI
ScienceOn
|
14 |
S. Wold, A. Ruhe, H. Wold, and W. J. Dunn III, "The collinearity problem in linear regression. The partial least squares (PLS) approach to generalized inverses", SIAM Journal on Scientific and Statistical Computing, Vol. 5, pp 735-743, 1984.
DOI
|
15 |
G. Gentile, G. Merlo, A. Pozzan, G. Bernasconi, B. Bax, P. Bamborough, A. Bridges, P. Carter, M. Neu, G. Yao, C. Brough, G. Cutler, A. Coffin, and S. Belyanskaya, "5-Aryl-4-carboxamide-1,3-oxazoles: potent and selective GSK-3 inhibitors", Bioorg. Med. Chem. Lett., Vol. 22, pp. 1989-1994, 2012.
DOI
ScienceOn
|
16 |
R. G. Gentles, S. Hu, and G. M. Dubowchik, "Recent advances in the discovery of GSK-3 inhibitors and a perspective on their utility for the treatment of Alzheimer's disease", Annu. Rep. Med. Chem., Vol. 44, pp. 3-26, 2009.
DOI
|
17 |
M. Aoki, M. Iwamoto-Sugai, I. Sugiura, C. Sasaki, T. Hasegawa, C. Okumura, S. Sugio, T. Kohno, and T. Matsuzaki, "Expression, purification and crystallization of human tau-protein kinase I/glycogen synthase kinase-", Acta Crystallogr. D, Vol. 56, pp. 1464-1465, 2000.
DOI
ScienceOn
|
18 |
B. Bax, P. S. Carter, C. Lewis, A. R. Guy, A. Bridges, R. Tanner, G. Pettman, C. Mannix, A. A. Culbert, M. J. Brown, D. G. Smith, and A. D. Reith, "The structure of phosphorylated GSK- complexed with a peptide, FRATtide, that inhibits -catenin phosphorylation", Structure, Vol. 9, pp. 1143-1152, 2001.
DOI
ScienceOn
|
19 |
A. Balupuri and S. J. Cho, "Exploration of the binding mode of indole derivatives as potent HIV-1 inhibitors using molecular docking simulations", J. Chosun Natural Sci., Vol. 6, pp. 138-142, 2013.
DOI
ScienceOn
|
20 |
P. K. Balasubramanian, A. Balupuri, and S. J. Cho, "A CoMFA study of phenoxypyridine-based JNK3 inhibitors using various partial charge schemes", J. Chosun Natural Sci., Vol. 7, pp. 45-49, 2014.
DOI
ScienceOn
|
21 |
P. K. Balasubramanian, A. Balupuri, and S. J. Cho, "Ligand-based CoMFA study on pyridylpyrazolopyridine derivatives as PKCe kinase inhibitors", J. Chosun Natural Sci., Vol. 7, pp. 253-259, 2014.
DOI
ScienceOn
|